Ekso Bionics (EKSO) Misses Q1 EPS by 13c

Ekso Bionics (NASDAQ: EKSO) reported Q1 EPS of ($0.20), $0.13 worse than the analyst estimate of ($0.07). Revenue for the quarter came in at $3.76 million versus the consensus estimate of $5.3 million.

For earnings history and earnings-related data on Ekso Bionics (EKSO) click here.

You May Also Be Interested In

• Wolfe Research starts Ferrari at Outperform, sees 'solid upside potential'
• ADNOC Distribution agrees to buy Shell's South Africa unit for $1B
• bioAffinity Technologies Q2 CyPath Lung sales rise over 200% year-over-year